L Eugene Arnold Selected Research

Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)

9/2022	Paediatric adverse event rating scale: a measure of safety or efficacy? Novel analysis from the MADDY study.
3/2022	Pain sensitivity and perceptual sensitivity are associated with severity of emotional dysregulation in children with ADHD: a cross-sectional analysis using the Temperament in Middle Childhood Questionnaire.
3/2022	Characterizing Underlying Cognitive Components of ADHD Presentations and Co-morbid Diagnoses: A Diffusion Decision Model Analysis.
2/2022	Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD.
1/2022	Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial.
1/2021	Editorial: A Special Tree in the Forest: From Oak to Acorn to Oak.
1/2021	A Qualitative Analysis of Contextual Factors Relevant to Suspected Late-Onset ADHD.
12/2020	Childhood ADHD and Involvement in Early Pregnancy: Mechanisms of Risk.
11/2020	Maternal personality traits moderate treatment response in the Multimodal Treatment Study of attention-deficit/hyperactivity disorder.
3/2020	EEG Theta/Beta Ratio Calculations Differ Between Various EEG Neurofeedback and Assessment Software Packages: Clinical Interpretation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Eugene Arnold Research Topics

Disease

123	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2022 - 05/2002
30	Autistic Disorder (Autism) 09/2020 - 08/2002
24	Autism Spectrum Disorder 01/2020 - 10/2006
11	Weight Gain 10/2017 - 08/2002
9	Substance-Related Disorders (Drug Abuse) 03/2020 - 08/2007
7	Mood Disorders (Mood Disorder) 03/2019 - 09/2015
7	Attention Deficit and Disruptive Behavior Disorders (Disruptive Behavior Disorder) 02/2017 - 06/2011
6	Oppositional Defiant Disorder 03/2022 - 10/2003
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 12/2015
3	Overweight 01/2018 - 09/2016
3	Mania (Manias) 06/2016 - 08/2011
3	Mental Disorders (Mental Disorder) 07/2014 - 05/2007
3	Intellectual Disability (Idiocy) 06/2014 - 01/2003
2	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2020 - 04/2017
2	Conduct Disorder (Conduct Disorders) 03/2020 - 09/2014
2	Weight Loss (Weight Reduction) 10/2017 - 11/2015
2	Asperger Syndrome (Asperger's Syndrome) 09/2016 - 02/2007
2	Psychotic Disorders (Schizoaffective Disorder) 09/2015 - 08/2011
2	Enuresis 08/2015 - 12/2005
2	Antisocial Personality Disorder (Antisocial Personality) 01/2014 - 09/2012
2	Confusion (Bewilderment) 07/2008 - 07/2008
2	Sialorrhea 12/2005 - 08/2002
1	Myopia 2 01/2021
1	Diarrhea 09/2020
1	Vomiting 09/2020
1	Marijuana Use 03/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Major Depressive Disorder (Major Depressive Disorders) 01/2018
1	Body Weight (Weight, Body) 01/2017
1	Tardive Dyskinesia 01/2017
1	Ocular Motility Disorders (Convergence Insufficiency) 10/2016
1	Insulin Resistance 01/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Hyperprolactinemia 01/2016
1	Cyclothymic Disorder 12/2015
1	Epilepsy (Aura) 07/2014
1	Learning Disabilities (Learning Disability) 07/2014
1	Developmental Disabilities (Developmental Disability) 06/2014
1	Obesity 09/2012

Drug/Important Bio-Agent (IBA)

47	Pemetrexed (MTA)FDA Link 02/2022 - 05/2002
30	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2020 - 08/2002
14	Methylphenidate (Ritalin)FDA LinkGeneric 01/2020 - 01/2003
12	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 06/2018 - 09/2005
11	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 08/2002
8	Pharmaceutical PreparationsIBA 03/2020 - 06/2005
5	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 09/2015
4	MicronutrientsIBA 09/2022 - 12/2019
4	Biological ProductsIBA 12/2019 - 08/2012
4	ProlactinIBA 01/2017 - 02/2007
4	ZincIBA 02/2011 - 08/2005
3	Vitamin D FDA LinkGeneric 01/2021 - 01/2016
3	Illicit Drugs (Recreational Drugs)IBA 03/2020 - 01/2018
3	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 09/2016
3	Fatty Acids (Saturated Fatty Acids)IBA 04/2017 - 12/2007
3	IronIBA 01/2016 - 12/2010
3	Amphetamine (Amfetamine)FDA LinkGeneric 02/2011 - 11/2007
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 03/2022 - 05/2006
2	VitaminsIBA 01/2022 - 12/2019
2	Fluoxetine (Prozac)FDA LinkGeneric 09/2020 - 09/2005
2	MineralsIBA 12/2019 - 10/2011
2	Varenicline (Chantix)FDA Link 11/2016 - 02/2013
2	Ferritins (Ferritin)IBA 01/2016 - 12/2010
2	LeptinIBA 01/2016 - 06/2004
2	Guanfacine (Tenex)FDA LinkGeneric 02/2010 - 12/2003
2	Dopamine (Intropin)FDA LinkGeneric 05/2006 - 08/2002
1	25-hydroxyvitamin DIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Vitamin D-Binding ProteinIBA 01/2018
1	AntibodiesIBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2017
1	Aripiprazole (Abilify)FDA Link 04/2017
1	Amitriptyline (Elavil)FDA LinkGeneric 04/2017
1	Loxapine (Loxitane)FDA LinkGeneric 04/2017
1	Dopamine AntagonistsIBA 04/2017
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2017
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 01/2017
1	Capsules (Microcapsules)IBA 01/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	CalciumIBA 01/2016
1	Alanine Transaminase (SGPT)IBA 01/2016
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Insulin (Novolin)FDA Link 01/2016
1	trans-sodium crocetinate (crocetin)IBA 12/2015
1	salicylhydroxamic acid (SHAM)IBA 07/2013
1	Soaps (Soap)IBA 06/2013
1	Aligeron (AS 2)IBA 09/2012

Therapy/Procedure

66	Combined Modality Therapy 02/2022 - 05/2002
10	Therapeutics 01/2018 - 08/2002
6	Neurofeedback 03/2020 - 07/2012
3	Aftercare (After-Treatment) 10/2016 - 05/2009
1	Lenses 01/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2021
1	Transcranial Direct Current Stimulation 06/2016
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2014